&nbsp;

Aug 2025

Drug

azaCITIDine

Other Name(s): Vidaza®

Quick Link(s):

Sep 2025

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Jun 2025

Drug

trametinib

Other Name(s): Mekinist®

Quick Link(s):

Jun 2025

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Sep 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Regimen

TMZL

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

TRAM

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

Exceptional Access Program

trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria

Drugs Used:

trametinib

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

TOPO(W)

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to criteria

Drugs Used:

alectinib

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

TMZL

Cancer Type:

Central Nervous System

Intent: Adjuvant

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

AVEL

Cancer Type:

Skin,

Merkel Cell

Intent: Palliative

Funding:

New Drug Funding Program

Avelumab - Metastatic Merkel Cell Carcinoma

Drugs Used:

avelumab